메뉴 건너뛰기




Volumn 88, Issue 6, 2012, Pages 465-475

The B7 Homologues and their Receptors in Hematologic Malignancies

Author keywords

B7 H1; Costimulation; Leukemia; Lymphoma; PD 1; T cell

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; T LYMPHOCYTE RECEPTOR;

EID: 84862802626     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2012.01766.x     Document Type: Review
Times cited : (17)

References (131)
  • 4
    • 34247157223 scopus 로고    scopus 로고
    • The new B7s: playing a pivotal role in tumor immunity
    • Flies DB, Chen L. The new B7s: playing a pivotal role in tumor immunity. J Immunother 2007;30:251-60.
    • (2007) J Immunother , vol.30 , pp. 251-260
    • Flies, D.B.1    Chen, L.2
  • 5
    • 44349150012 scopus 로고    scopus 로고
    • Inhibitory B7-family molecules in the tumour microenvironment
    • Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008;8:467-77.
    • (2008) Nat Rev Immunol , vol.8 , pp. 467-477
    • Zou, W.1    Chen, L.2
  • 6
    • 65349130644 scopus 로고    scopus 로고
    • Fine tuning the immune response through B7-H3 and B7-H4
    • Yi KH, Chen L. Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev 2009;229:145-51.
    • (2009) Immunol Rev , vol.229 , pp. 145-151
    • Yi, K.H.1    Chen, L.2
  • 7
    • 0014941813 scopus 로고
    • A theory of self-nonself discrimination
    • Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970;169:1042-9.
    • (1970) Science , vol.169 , pp. 1042-1049
    • Bretscher, P.1    Cohn, M.2
  • 9
    • 77956527537 scopus 로고    scopus 로고
    • Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes
    • Kondo A, Yamashita T, Tamura H, et al. Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes. Blood 2010;116:1124-31.
    • (2010) Blood , vol.116 , pp. 1124-1131
    • Kondo, A.1    Yamashita, T.2    Tamura, H.3
  • 10
    • 77957657109 scopus 로고    scopus 로고
    • In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
    • Berthon C, Driss V, Liu J, Kuranda K, Leleu X, Jouy N, Hetuin D, Quesnel B. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunol Immunother 2010;59:1839-49.
    • (2010) Cancer Immunol Immunother , vol.59 , pp. 1839-1849
    • Berthon, C.1    Driss, V.2    Liu, J.3    Kuranda, K.4    Leleu, X.5    Jouy, N.6    Hetuin, D.7    Quesnel, B.8
  • 12
    • 56149113642 scopus 로고    scopus 로고
    • Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia
    • Chen X, Liu S, Wang L, Zhang W, Ji Y, Ma X. Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia. Cancer Biol Ther 2008;7:622-7.
    • (2008) Cancer Biol Ther , vol.7 , pp. 622-627
    • Chen, X.1    Liu, S.2    Wang, L.3    Zhang, W.4    Ji, Y.5    Ma, X.6
  • 13
    • 67349109903 scopus 로고    scopus 로고
    • B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells
    • Ge W, Ma X, Li X, Wang Y, Li C, Meng H, Liu X, Yu Z, You S, Qiu L. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells. Leuk Res 2009;33:948-57.
    • (2009) Leuk Res , vol.33 , pp. 948-957
    • Ge, W.1    Ma, X.2    Li, X.3    Wang, Y.4    Li, C.5    Meng, H.6    Liu, X.7    Yu, Z.8    You, S.9    Qiu, L.10
  • 14
    • 79960318715 scopus 로고    scopus 로고
    • Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells
    • Andorsky DJ, Yamada RE, Said J, Pinkus GS, Betting DJ, Timmerman JM. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells. Clin Cancer Res 2011;17:4232-44.
    • (2011) Clin Cancer Res , vol.17 , pp. 4232-4244
    • Andorsky, D.J.1    Yamada, R.E.2    Said, J.3    Pinkus, G.S.4    Betting, D.J.5    Timmerman, J.M.6
  • 15
    • 42449147063 scopus 로고    scopus 로고
    • PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
    • Yamamoto R, Nishikori M, Kitawaki T, et al. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 2008;111:3220-4.
    • (2008) Blood , vol.111 , pp. 3220-3224
    • Yamamoto, R.1    Nishikori, M.2    Kitawaki, T.3
  • 16
    • 78049370405 scopus 로고    scopus 로고
    • Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
    • Green MR, Monti S, Rodig SJ, et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 2010;116:3268-77.
    • (2010) Blood , vol.116 , pp. 3268-3277
    • Green, M.R.1    Monti, S.2    Rodig, S.J.3
  • 17
    • 34347400169 scopus 로고    scopus 로고
    • Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway
    • Liu J, Hamrouni A, Wolowiec D, Coiteux V, Kuliczkowski K, Hetuin D, Saudemont A, Quesnel B. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood 2007;110:296-304.
    • (2007) Blood , vol.110 , pp. 296-304
    • Liu, J.1    Hamrouni, A.2    Wolowiec, D.3    Coiteux, V.4    Kuliczkowski, K.5    Hetuin, D.6    Saudemont, A.7    Quesnel, B.8
  • 18
    • 70349234325 scopus 로고    scopus 로고
    • B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
    • Wilcox RA, Feldman AL, Wada DA, et al. B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood 2009;114:2149-58.
    • (2009) Blood , vol.114 , pp. 2149-2158
    • Wilcox, R.A.1    Feldman, A.L.2    Wada, D.A.3
  • 19
    • 84856232584 scopus 로고    scopus 로고
    • Expression patterns of the immunosuppressive proteins PD-1/CD279 and PD-L1/CD274 at different stages of cutaneous T-cell lymphoma/mycosis fungoides
    • Kantekure K, Yang Y, Raghunath P, Schaffer A, Woetmann A, Zhang Q, Odum N, Wasik M. Expression patterns of the immunosuppressive proteins PD-1/CD279 and PD-L1/CD274 at different stages of cutaneous T-cell lymphoma/mycosis fungoides. Am J Dermatopathol 2011;34:126-8.
    • (2011) Am J Dermatopathol , vol.34 , pp. 126-128
    • Kantekure, K.1    Yang, Y.2    Raghunath, P.3    Schaffer, A.4    Woetmann, A.5    Zhang, Q.6    Odum, N.7    Wasik, M.8
  • 20
    • 60149109928 scopus 로고    scopus 로고
    • PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
    • Kozako T, Yoshimitsu M, Fujiwara H, et al. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. Leukemia 2009;23:375-82.
    • (2009) Leukemia , vol.23 , pp. 375-382
    • Kozako, T.1    Yoshimitsu, M.2    Fujiwara, H.3
  • 21
    • 23844439584 scopus 로고    scopus 로고
    • Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia
    • Tamura H, Dan K, Tamada K, Nakamura K, Shioi Y, Hyodo H, Wang SD, Dong H, Chen L, Ogata K. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Clin Cancer Res 2005;11:5708-17.
    • (2005) Clin Cancer Res , vol.11 , pp. 5708-5717
    • Tamura, H.1    Dan, K.2    Tamada, K.3    Nakamura, K.4    Shioi, Y.5    Hyodo, H.6    Wang, S.D.7    Dong, H.8    Chen, L.9    Ogata, K.10
  • 24
    • 84862821796 scopus 로고    scopus 로고
    • Expression of B7-H3 (CD276) an Immunoregulatory Cell Surface Molecule in Non-Hodgkin Lymphomas Identified by Mass Spectrometry. Presented at: Annual Meeting of the United States and Canadian Academy of Pathology
    • Wey EA, Laliberta J, McNeil C, Basrur V, Keyoumarsi F, Thomas D, Suh C, Huh J, Elenitoba-Johnson K, Lim MS. Expression of B7-H3 (CD276) an Immunoregulatory Cell Surface Molecule in Non-Hodgkin Lymphomas Identified by Mass Spectrometry. Presented at: Annual Meeting of the United States and Canadian Academy of Pathology. 2011.
    • (2011)
    • Wey, E.A.1    Laliberta, J.2    McNeil, C.3    Basrur, V.4    Keyoumarsi, F.5    Thomas, D.6    Suh, C.7    Huh, J.8    Elenitoba-Johnson, K.9    Lim, M.S.10
  • 25
    • 0034667688 scopus 로고    scopus 로고
    • Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS
    • Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, Chen L. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000;96:2808-13.
    • (2000) Blood , vol.96 , pp. 2808-2813
    • Wang, S.1    Zhu, G.2    Chapoval, A.I.3    Dong, H.4    Tamada, K.5    Ni, J.6    Chen, L.7
  • 26
    • 0033212778 scopus 로고    scopus 로고
    • B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha
    • Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 1999;11:423-32.
    • (1999) Immunity , vol.11 , pp. 423-432
    • Swallow, M.M.1    Wallin, J.J.2    Sha, W.C.3
  • 27
    • 0033576707 scopus 로고    scopus 로고
    • T-cell co-stimulation through B7RP-1 and ICOS
    • Yoshinaga SK, Whoriskey JS, Khare SD, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999;402:827-32.
    • (1999) Nature , vol.402 , pp. 827-832
    • Yoshinaga, S.K.1    Whoriskey, J.S.2    Khare, S.D.3
  • 30
    • 79954577066 scopus 로고    scopus 로고
    • B7-h2 is a costimulatory ligand for CD28 in human
    • Yao S, Zhu Y, Zhu G, et al. B7-h2 is a costimulatory ligand for CD28 in human. Immunity 2011;34:729-40.
    • (2011) Immunity , vol.34 , pp. 729-740
    • Yao, S.1    Zhu, Y.2    Zhu, G.3
  • 32
    • 0038433329 scopus 로고    scopus 로고
    • B7S1, a novel B7 family member that negatively regulates T cell activation
    • Prasad DV, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003;18:863-73.
    • (2003) Immunity , vol.18 , pp. 863-873
    • Prasad, D.V.1    Richards, S.2    Mai, X.M.3    Dong, C.4
  • 34
    • 48749093493 scopus 로고    scopus 로고
    • Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses
    • Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, Azuma M. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci USA 2008;105:10495-500.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 10495-10500
    • Hashiguchi, M.1    Kobori, H.2    Ritprajak, P.3    Kamimura, Y.4    Kozono, H.5    Azuma, M.6
  • 35
    • 77953523681 scopus 로고    scopus 로고
    • Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites
    • Kobori H, Hashiguchi M, Piao J, Kato M, Ritprajak P, Azuma M. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites. Immunology 2010;130:363-73.
    • (2010) Immunology , vol.130 , pp. 363-373
    • Kobori, H.1    Hashiguchi, M.2    Piao, J.3    Kato, M.4    Ritprajak, P.5    Azuma, M.6
  • 36
    • 69249135880 scopus 로고    scopus 로고
    • B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction
    • Leitner J, Klauser C, Pickl WF, et al. B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction. Eur J Immunol 2009;39:1754-64.
    • (2009) Eur J Immunol , vol.39 , pp. 1754-1764
    • Leitner, J.1    Klauser, C.2    Pickl, W.F.3
  • 37
    • 0033180181 scopus 로고    scopus 로고
    • Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
    • Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999;11:141-51.
    • (1999) Immunity , vol.11 , pp. 141-151
    • Nishimura, H.1    Nose, M.2    Hiai, H.3    Minato, N.4    Honjo, T.5
  • 38
    • 0035846991 scopus 로고    scopus 로고
    • Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
    • Nishimura H, Okazaki T, Tanaka Y, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001;291:319-22.
    • (2001) Science , vol.291 , pp. 319-322
    • Nishimura, H.1    Okazaki, T.2    Tanaka, Y.3
  • 39
    • 23844529169 scopus 로고    scopus 로고
    • Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes
    • Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA 2005;102:11823-8.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 11823-11828
    • Wang, J.1    Yoshida, T.2    Nakaki, F.3    Hiai, H.4    Okazaki, T.5    Honjo, T.6
  • 40
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23.
    • (2010) N Engl J Med , vol.363 , pp. 711-723
    • Hodi, F.S.1    O'Day, S.J.2    McDermott, D.F.3
  • 41
    • 49649114804 scopus 로고    scopus 로고
    • Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
    • Berger R, Rotem-Yehudar R, Slama G, Landes S, Kneller A, Leiba M, Koren-Michowitz M, Shimoni A, Nagler A. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res 2008;14:3044-51.
    • (2008) Clin Cancer Res , vol.14 , pp. 3044-3051
    • Berger, R.1    Rotem-Yehudar, R.2    Slama, G.3    Landes, S.4    Kneller, A.5    Leiba, M.6    Koren-Michowitz, M.7    Shimoni, A.8    Nagler, A.9
  • 42
    • 77954899030 scopus 로고    scopus 로고
    • Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
    • Brahmer JR, Drake CG, Wollner I, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010;28:3167-75.
    • (2010) J Clin Oncol , vol.28 , pp. 3167-3175
    • Brahmer, J.R.1    Drake, C.G.2    Wollner, I.3
  • 43
    • 65349118810 scopus 로고    scopus 로고
    • PD-1 signaling in primary T cells
    • Riley JL. PD-1 signaling in primary T cells. Immunol Rev 2009;229:114-25.
    • (2009) Immunol Rev , vol.229 , pp. 114-125
    • Riley, J.L.1
  • 44
    • 34447646310 scopus 로고    scopus 로고
    • Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
    • Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007;27:111-22.
    • (2007) Immunity , vol.27 , pp. 111-122
    • Butte, M.J.1    Keir, M.E.2    Phamduy, T.B.3    Sharpe, A.H.4    Freeman, G.J.5
  • 46
    • 33748947326 scopus 로고    scopus 로고
    • PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
    • Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443:350-4.
    • (2006) Nature , vol.443 , pp. 350-354
    • Day, C.L.1    Kaufmann, D.E.2    Kiepiela, P.3
  • 47
    • 34249711903 scopus 로고    scopus 로고
    • PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors
    • Zhang JY, Zhang Z, Wang X, et al. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007;109:4671-8.
    • (2007) Blood , vol.109 , pp. 4671-4678
    • Zhang, J.Y.1    Zhang, Z.2    Wang, X.3
  • 48
    • 78650478671 scopus 로고    scopus 로고
    • Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression
    • Samimi S, Benoit B, Evans K, Wherry EJ, Showe L, Wysocka M, Rook AH. Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression. Arch Dermatol 2010;146:1382-8.
    • (2010) Arch Dermatol , vol.146 , pp. 1382-1388
    • Samimi, S.1    Benoit, B.2    Evans, K.3    Wherry, E.J.4    Showe, L.5    Wysocka, M.6    Rook, A.H.7
  • 49
    • 77957701558 scopus 로고    scopus 로고
    • The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
    • Benson DM Jr, Bakan CE, Mishra A, et al. The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood 2010;116:2286-94.
    • (2010) Blood , vol.116 , pp. 2286-2294
    • Benson Jr., D.M.1    Bakan, C.E.2    Mishra, A.3
  • 50
    • 36849024949 scopus 로고    scopus 로고
    • Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo
    • Reddy N, Hernandez-Ilizaliturri FJ, Deeb G, Roth M, Vaughn M, Knight J, Wallace P, Czuczman MS. Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo. Br J Haematol 2008;140:36-45.
    • (2008) Br J Haematol , vol.140 , pp. 36-45
    • Reddy, N.1    Hernandez-Ilizaliturri, F.J.2    Deeb, G.3    Roth, M.4    Vaughn, M.5    Knight, J.6    Wallace, P.7    Czuczman, M.S.8
  • 51
    • 51649123319 scopus 로고    scopus 로고
    • Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells
    • Wu L, Adams M, Carter T, Chen R, Muller G, Stirling D, Schafer P, Bartlett JB. Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. Clin Cancer Res 2008;14:4650-7.
    • (2008) Clin Cancer Res , vol.14 , pp. 4650-4657
    • Wu, L.1    Adams, M.2    Carter, T.3    Chen, R.4    Muller, G.5    Stirling, D.6    Schafer, P.7    Bartlett, J.B.8
  • 52
    • 84863393455 scopus 로고    scopus 로고
    • Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD
    • Wiesmayr S, Webber SA, Macedo C, Popescu I, Smith L, Luce J, Metes D. Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD. Eur J Immunol 2011;42:541-50.
    • (2011) Eur J Immunol , vol.42 , pp. 541-550
    • Wiesmayr, S.1    Webber, S.A.2    Macedo, C.3    Popescu, I.4    Smith, L.5    Luce, J.6    Metes, D.7
  • 53
    • 0036784633 scopus 로고    scopus 로고
    • Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells
    • Ogasawara K, Yoshinaga SK, Lanier LL. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J Immunol 2002;169:3676-85.
    • (2002) J Immunol , vol.169 , pp. 3676-3685
    • Ogasawara, K.1    Yoshinaga, S.K.2    Lanier, L.L.3
  • 54
    • 67650507057 scopus 로고    scopus 로고
    • The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
    • Brandt CS, Baratin M, Yi EC, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 2009;206:1495-503.
    • (2009) J Exp Med , vol.206 , pp. 1495-1503
    • Brandt, C.S.1    Baratin, M.2    Yi, E.C.3
  • 55
    • 79955031874 scopus 로고    scopus 로고
    • Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site
    • Joyce MG, Tran P, Zhuravleva MA, Jaw J, Colonna M, Sun PD. Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site. Proc Natl Acad Sci USA 2011;108:6223-8.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 6223-6228
    • Joyce, M.G.1    Tran, P.2    Zhuravleva, M.A.3    Jaw, J.4    Colonna, M.5    Sun, P.D.6
  • 56
    • 79955706257 scopus 로고    scopus 로고
    • Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6
    • Li Y, Wang Q, Mariuzza RA. Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6. J Exp Med 2011;208:703-14.
    • (2011) J Exp Med , vol.208 , pp. 703-714
    • Li, Y.1    Wang, Q.2    Mariuzza, R.A.3
  • 57
    • 77954255971 scopus 로고    scopus 로고
    • Cancer-associated myeloproliferation: old association, new therapeutic target
    • Wilcox RA. Cancer-associated myeloproliferation: old association, new therapeutic target. Mayo Clin Proc 2010;85:656-63.
    • (2010) Mayo Clin Proc , vol.85 , pp. 656-663
    • Wilcox, R.A.1
  • 58
    • 84862821799 scopus 로고    scopus 로고
    • The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma
    • Epub ahead of print
    • Wilcox RA, Ristow K, Habermann TM, et al. The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma. Leuk Lymphoma 2011. [Epub ahead of print].
    • (2011) Leuk Lymphoma
    • Wilcox, R.A.1    Ristow, K.2    Habermann, T.M.3
  • 59
    • 80052452315 scopus 로고    scopus 로고
    • The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
    • Wilcox RA, Ristow K, Habermann TM, et al. The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia 2011;25:1502-9.
    • (2011) Leukemia , vol.25 , pp. 1502-1509
    • Wilcox, R.A.1    Ristow, K.2    Habermann, T.M.3
  • 60
    • 77949345555 scopus 로고    scopus 로고
    • Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
    • Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010;362:875-85.
    • (2010) N Engl J Med , vol.362 , pp. 875-885
    • Steidl, C.1    Lee, T.2    Shah, S.P.3
  • 61
    • 84856446578 scopus 로고    scopus 로고
    • Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin lymphoma
    • Porrata LF, Ristow K, Colgan J, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin lymphoma. Haematologica 2011;97:262-9.
    • (2011) Haematologica , vol.97 , pp. 262-269
    • Porrata, L.F.1    Ristow, K.2    Colgan, J.3
  • 62
    • 79959271214 scopus 로고    scopus 로고
    • Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
    • Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011;117:6532-41.
    • (2011) Blood , vol.117 , pp. 6532-6541
    • Hoechst, B.1    Gamrekelashvili, J.2    Manns, M.P.3    Greten, T.F.4    Korangy, F.5
  • 65
    • 57249086246 scopus 로고    scopus 로고
    • Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes
    • Dolganiuc A, Paek E, Kodys K, Thomas J, Szabo G. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 2008;135:2119-27.
    • (2008) Gastroenterology , vol.135 , pp. 2119-2127
    • Dolganiuc, A.1    Paek, E.2    Kodys, K.3    Thomas, J.4    Szabo, G.5
  • 66
    • 34547957665 scopus 로고    scopus 로고
    • CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)
    • Kordasti SY, Ingram W, Hayden J, et al. CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood 2007;110:847-50.
    • (2007) Blood , vol.110 , pp. 847-850
    • Kordasti, S.Y.1    Ingram, W.2    Hayden, J.3
  • 69
    • 33646422454 scopus 로고    scopus 로고
    • Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
    • Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 2006;107:3639-46.
    • (2006) Blood , vol.107 , pp. 3639-3646
    • Yang, Z.Z.1    Novak, A.J.2    Stenson, M.J.3    Witzig, T.E.4    Ansell, S.M.5
  • 70
    • 83055164370 scopus 로고    scopus 로고
    • Malignant B cells induce the conversion of CD4CD25 T cells to regulatory T cells in B-cell non-hodgkin lymphoma
    • Han Y, Wu J, Bi L, Xiong S, Gao S, Yin L, Jiang L, Chen C, Yu K, Zhang S. Malignant B cells induce the conversion of CD4CD25 T cells to regulatory T cells in B-cell non-hodgkin lymphoma. PLoS One 2011;6:e28649.
    • (2011) PLoS One , vol.6
    • Han, Y.1    Wu, J.2    Bi, L.3    Xiong, S.4    Gao, S.5    Yin, L.6    Jiang, L.7    Chen, C.8    Yu, K.9    Zhang, S.10
  • 71
    • 77957747417 scopus 로고    scopus 로고
    • Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia
    • Zhou Q, Munger ME, Highfill SL, et al. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood 2010;116:2484-93.
    • (2010) Blood , vol.116 , pp. 2484-2493
    • Zhou, Q.1    Munger, M.E.2    Highfill, S.L.3
  • 72
    • 79957891364 scopus 로고    scopus 로고
    • PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine
    • Rosenblatt J, Glotzbecker B, Mills H, et al. PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine. J Immunother 2011;34:409-18.
    • (2011) J Immunother , vol.34 , pp. 409-418
    • Rosenblatt, J.1    Glotzbecker, B.2    Mills, H.3
  • 73
    • 43549115533 scopus 로고    scopus 로고
    • B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
    • Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood 2008;111:3635-43.
    • (2008) Blood , vol.111 , pp. 3635-3643
    • Azuma, T.1    Yao, S.2    Zhu, G.3    Flies, A.S.4    Flies, S.J.5    Chen, L.6
  • 75
    • 79958746233 scopus 로고    scopus 로고
    • B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation
    • Liu H, Tekle C, Chen YW, et al. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther 2011;10:960-71.
    • (2011) Mol Cancer Ther , vol.10 , pp. 960-971
    • Liu, H.1    Tekle, C.2    Chen, Y.W.3
  • 76
    • 18844373949 scopus 로고    scopus 로고
    • The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation
    • Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, Liu W, Pilkington G, Papkoff J. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 2005;306:128-41.
    • (2005) Exp Cell Res , vol.306 , pp. 128-141
    • Salceda, S.1    Tang, T.2    Kmet, M.3    Munteanu, A.4    Ghosh, M.5    Macina, R.6    Liu, W.7    Pilkington, G.8    Papkoff, J.9
  • 77
    • 58549102319 scopus 로고    scopus 로고
    • Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
    • Marzec M, Zhang Q, Goradia A, et al. Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad Sci USA 2008;105:20852-7.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 20852-20857
    • Marzec, M.1    Zhang, Q.2    Goradia, A.3
  • 78
    • 80052945186 scopus 로고    scopus 로고
    • Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS
    • Zhang Q, Wang H, Kantekure K, et al. Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS. Blood 2011;118:3062-71.
    • (2011) Blood , vol.118 , pp. 3062-3071
    • Zhang, Q.1    Wang, H.2    Kantekure, K.3
  • 80
    • 80052673612 scopus 로고    scopus 로고
    • The molecular pathogenesis of primary mediastinal large B-cell lymphoma
    • Steidl C, Gascoyne RD. The molecular pathogenesis of primary mediastinal large B-cell lymphoma. Blood 2011;118:2659-69.
    • (2011) Blood , vol.118 , pp. 2659-2669
    • Steidl, C.1    Gascoyne, R.D.2
  • 81
    • 79952075257 scopus 로고    scopus 로고
    • Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies
    • Tefferi A, Vainchenker W. Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol 2011;29:573-82.
    • (2011) J Clin Oncol , vol.29 , pp. 573-582
    • Tefferi, A.1    Vainchenker, W.2
  • 82
    • 79952816655 scopus 로고    scopus 로고
    • MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
    • Steidl C, Shah SP, Woolcock BW, et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011;471:377-81.
    • (2011) Nature , vol.471 , pp. 377-381
    • Steidl, C.1    Shah, S.P.2    Woolcock, B.W.3
  • 83
    • 79952675131 scopus 로고    scopus 로고
    • Follicular helper CD4 T cells (TFH)
    • Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011;29:621-63.
    • (2011) Annu Rev Immunol , vol.29 , pp. 621-663
    • Crotty, S.1
  • 84
    • 76449086166 scopus 로고    scopus 로고
    • Advances in the understanding and management of angioimmunoblastic T-cell lymphoma
    • de Leval L, Gisselbrecht C, Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 2010;148:673-89.
    • (2010) Br J Haematol , vol.148 , pp. 673-689
    • de Leval, L.1    Gisselbrecht, C.2    Gaulard, P.3
  • 85
    • 36348982897 scopus 로고    scopus 로고
    • Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation
    • Piccaluga PP, Agostinelli C, Califano A, et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007;67:10703-10.
    • (2007) Cancer Res , vol.67 , pp. 10703-10710
    • Piccaluga, P.P.1    Agostinelli, C.2    Califano, A.3
  • 86
    • 33746877544 scopus 로고    scopus 로고
    • Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma
    • Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2006;30:802-10.
    • (2006) Am J Surg Pathol , vol.30 , pp. 802-810
    • Dorfman, D.M.1    Brown, J.A.2    Shahsafaei, A.3    Freeman, G.J.4
  • 87
    • 35748959075 scopus 로고    scopus 로고
    • Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma
    • Roncador G, Garcia Verdes-Montenegro JF, Tedoldi S, et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007;92:1059-66.
    • (2007) Haematologica , vol.92 , pp. 1059-1066
    • Roncador, G.1    Garcia Verdes-Montenegro, J.F.2    Tedoldi, S.3
  • 88
    • 45049087313 scopus 로고    scopus 로고
    • Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia
    • Xerri L, Chetaille B, Serriari N, Attias C, Guillaume Y, Arnoulet C, Olive D. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol 2008;39:1050-8.
    • (2008) Hum Pathol , vol.39 , pp. 1050-1058
    • Xerri, L.1    Chetaille, B.2    Serriari, N.3    Attias, C.4    Guillaume, Y.5    Arnoulet, C.6    Olive, D.7
  • 89
    • 58549117128 scopus 로고    scopus 로고
    • Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma
    • Yu H, Shahsafaei A, Dorfman DM. Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol 2009;131:33-41.
    • (2009) Am J Clin Pathol , vol.131 , pp. 33-41
    • Yu, H.1    Shahsafaei, A.2    Dorfman, D.M.3
  • 91
    • 65449136285 scopus 로고    scopus 로고
    • Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas
    • Huang Y, Moreau A, Dupuis J, et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 2009;33:682-90.
    • (2009) Am J Surg Pathol , vol.33 , pp. 682-690
    • Huang, Y.1    Moreau, A.2    Dupuis, J.3
  • 92
    • 67349116066 scopus 로고    scopus 로고
    • Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers
    • Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Mod Pathol 2009;22:753-61.
    • (2009) Mod Pathol , vol.22 , pp. 753-761
    • Rodriguez-Justo, M.1    Attygalle, A.D.2    Munson, P.3    Roncador, G.4    Marafioti, T.5    Piris, M.A.6
  • 93
    • 77949719442 scopus 로고    scopus 로고
    • The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation
    • Marafioti T, Paterson JC, Ballabio E, et al. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica 2010;95:432-9.
    • (2010) Haematologica , vol.95 , pp. 432-439
    • Marafioti, T.1    Paterson, J.C.2    Ballabio, E.3
  • 94
    • 79959328032 scopus 로고    scopus 로고
    • ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6
    • Choi YS, Kageyama R, Eto D, Escobar TC, Johnston RJ, Monticelli L, Lao C, Crotty S. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 2011;34:932-46.
    • (2011) Immunity , vol.34 , pp. 932-946
    • Choi, Y.S.1    Kageyama, R.2    Eto, D.3    Escobar, T.C.4    Johnston, R.J.5    Monticelli, L.6    Lao, C.7    Crotty, S.8
  • 95
    • 0037340349 scopus 로고    scopus 로고
    • Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency
    • Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003;4:261-8.
    • (2003) Nat Immunol , vol.4 , pp. 261-268
    • Grimbacher, B.1    Hutloff, A.2    Schlesier, M.3
  • 96
    • 7044224342 scopus 로고    scopus 로고
    • ICOS deficiency in patients with common variable immunodeficiency
    • Salzer U, Maul-Pavicic A, Cunningham-Rundles C, et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 2004;113:234-40.
    • (2004) Clin Immunol , vol.113 , pp. 234-240
    • Salzer, U.1    Maul-Pavicic, A.2    Cunningham-Rundles, C.3
  • 97
    • 21144438325 scopus 로고    scopus 로고
    • A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity
    • Vinuesa CG, Cook MC, Angelucci C, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005;435:452-8.
    • (2005) Nature , vol.435 , pp. 452-458
    • Vinuesa, C.G.1    Cook, M.C.2    Angelucci, C.3
  • 99
    • 59149085520 scopus 로고    scopus 로고
    • Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers
    • Rodriguez Pinilla SM, Roncador G, Rodriguez-Peralto JL, et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 2009;33:81-90.
    • (2009) Am J Surg Pathol , vol.33 , pp. 81-90
    • Rodriguez Pinilla, S.M.1    Roncador, G.2    Rodriguez-Peralto, J.L.3
  • 100
    • 84355161676 scopus 로고    scopus 로고
    • Expression of programmed death-1 in primary cutaneous CD4-Positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma
    • Cetinozman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-Positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol 2012;36:109-16.
    • (2012) Am J Surg Pathol , vol.36 , pp. 109-116
    • Cetinozman, F.1    Jansen, P.M.2    Willemze, R.3
  • 101
    • 78449302113 scopus 로고    scopus 로고
    • Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis
    • Churchill HR, Roncador G, Warnke RA, Natkunam Y. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. Hum Pathol 2010;41:1726-34.
    • (2010) Hum Pathol , vol.41 , pp. 1726-1734
    • Churchill, H.R.1    Roncador, G.2    Warnke, R.A.3    Natkunam, Y.4
  • 103
    • 84860765637 scopus 로고    scopus 로고
    • Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells
    • Epub ahead of print
    • Ame-Thomas P, Le PriolJ, Yssel H, et al. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells. Leukemia 2011. [Epub ahead of print].
    • (2011) Leukemia
    • Ame-Thomas, P.1    Le, P.2    Yssel, H.3
  • 104
    • 80053353234 scopus 로고    scopus 로고
    • Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation
    • Hilchey SP, Rosenberg AF, Hyrien O, et al. Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation. Blood 2011;118:3591-602.
    • (2011) Blood , vol.118 , pp. 3591-3602
    • Hilchey, S.P.1    Rosenberg, A.F.2    Hyrien, O.3
  • 105
    • 74549151013 scopus 로고    scopus 로고
    • A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1 - positive, regulatory, cytotoxic, and helper T cells and macrophages
    • Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L, Christensson B, Sander B, Kimby E. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1 - positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res 2010;16:637-50.
    • (2010) Clin Cancer Res , vol.16 , pp. 637-650
    • Wahlin, B.E.1    Aggarwal, M.2    Montes-Moreno, S.3    Gonzalez, L.F.4    Roncador, G.5    Sanchez-Verde, L.6    Christensson, B.7    Sander, B.8    Kimby, E.9
  • 106
    • 67651099087 scopus 로고    scopus 로고
    • PD-1 on dendritic cells impedes innate immunity against bacterial infection
    • Yao S, Wang S, Zhu Y, et al. PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 2009;113:5811-8.
    • (2009) Blood , vol.113 , pp. 5811-5818
    • Yao, S.1    Wang, S.2    Zhu, Y.3
  • 107
    • 61849104513 scopus 로고    scopus 로고
    • B7-H4-deficient mice display augmented neutrophil-mediated innate immunity
    • Zhu G, Augustine MM, Azuma T, et al. B7-H4-deficient mice display augmented neutrophil-mediated innate immunity. Blood 2009;113:1759-67.
    • (2009) Blood , vol.113 , pp. 1759-1767
    • Zhu, G.1    Augustine, M.M.2    Azuma, T.3
  • 108
    • 0036220371 scopus 로고    scopus 로고
    • Chronic neutropenia associated with autoimmune disease
    • Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol 2002;39:121-7.
    • (2002) Semin Hematol , vol.39 , pp. 121-127
    • Starkebaum, G.1
  • 109
    • 0033850721 scopus 로고    scopus 로고
    • CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes
    • Coakley G, Iqbal M, Brooks D, Panayi GS, Lanchbury JS. CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Arthritis Rheum 2000;43:834-43.
    • (2000) Arthritis Rheum , vol.43 , pp. 834-843
    • Coakley, G.1    Iqbal, M.2    Brooks, D.3    Panayi, G.S.4    Lanchbury, J.S.5
  • 111
    • 45049087541 scopus 로고    scopus 로고
    • B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation
    • Song H, Park G, Kim YS, et al. B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation. Cancer Lett 2008;266:227-37.
    • (2008) Cancer Lett , vol.266 , pp. 227-237
    • Song, H.1    Park, G.2    Kim, Y.S.3
  • 112
    • 0035673393 scopus 로고    scopus 로고
    • Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH
    • Karadimitris A, Li K, Notaro R, et al. Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH. Br J Haematol 2001;115:1010-4.
    • (2001) Br J Haematol , vol.115 , pp. 1010-1014
    • Karadimitris, A.1    Li, K.2    Notaro, R.3
  • 113
    • 67650065350 scopus 로고    scopus 로고
    • Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset
    • Fozza C, Contini S, Galleu A, Simula MP, Virdis P, Bonfigli S, Longinotti M. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset. Exp Hematol 2009;37:947-55.
    • (2009) Exp Hematol , vol.37 , pp. 947-955
    • Fozza, C.1    Contini, S.2    Galleu, A.3    Simula, M.P.4    Virdis, P.5    Bonfigli, S.6    Longinotti, M.7
  • 114
    • 77954536742 scopus 로고    scopus 로고
    • In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome
    • Zheng Z, Qianqiao Z, Qi H, Feng X, Chunkang C, Xiao L. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Exp Hematol 2010;38:677-84.
    • (2010) Exp Hematol , vol.38 , pp. 677-684
    • Zheng, Z.1    Qianqiao, Z.2    Qi, H.3    Feng, X.4    Chunkang, C.5    Xiao, L.6
  • 115
    • 33644977449 scopus 로고    scopus 로고
    • Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia
    • Behl D, Porrata LF, Markovic SN, et al. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia 2006;20:29-34.
    • (2006) Leukemia , vol.20 , pp. 29-34
    • Behl, D.1    Porrata, L.F.2    Markovic, S.N.3
  • 116
    • 34247867850 scopus 로고    scopus 로고
    • Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas
    • Behl D, Ristow K, Markovic SN, et al. Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas. Br J Haematol 2007;137:409-15.
    • (2007) Br J Haematol , vol.137 , pp. 409-415
    • Behl, D.1    Ristow, K.2    Markovic, S.N.3
  • 118
    • 0036053424 scopus 로고    scopus 로고
    • Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia
    • Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM, Markovic SN. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 2002;16:1311-8.
    • (2002) Leukemia , vol.16 , pp. 1311-1318
    • Porrata, L.F.1    Litzow, M.R.2    Tefferi, A.3    Letendre, L.4    Kumar, S.5    Geyer, S.M.6    Markovic, S.N.7
  • 119
    • 59949095979 scopus 로고    scopus 로고
    • Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma
    • Porrata LF, Ristow K, Habermann TM, Witzig TE, Inwards DJ, Markovic SN. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma. Am J Hematol 2009;84:93-7.
    • (2009) Am J Hematol , vol.84 , pp. 93-97
    • Porrata, L.F.1    Ristow, K.2    Habermann, T.M.3    Witzig, T.E.4    Inwards, D.J.5    Markovic, S.N.6
  • 121
    • 77954656902 scopus 로고    scopus 로고
    • Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma
    • Porrata LF, Rsitow K, Inwards DJ, et al. Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma. Leukemia 2010;24:1343-9.
    • (2010) Leukemia , vol.24 , pp. 1343-1349
    • Porrata, L.F.1    Rsitow, K.2    Inwards, D.J.3
  • 122
    • 75749156156 scopus 로고    scopus 로고
    • New-onset lymphopenia assessed during routine follow-up is a risk factor for relapse postautologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma
    • Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, Markovic SN. New-onset lymphopenia assessed during routine follow-up is a risk factor for relapse postautologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma. Biol Blood Marrow Transplant 2010;16:376-83.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 376-383
    • Porrata, L.F.1    Inwards, D.J.2    Ansell, S.M.3    Micallef, I.N.4    Johnston, P.B.5    Hogan, W.J.6    Markovic, S.N.7
  • 125
    • 70349561448 scopus 로고    scopus 로고
    • PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
    • Zhang L, Gajewski TF, Kline J. PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Blood 2009;114:1545-52.
    • (2009) Blood , vol.114 , pp. 1545-1552
    • Zhang, L.1    Gajewski, T.F.2    Kline, J.3
  • 126
    • 4644256639 scopus 로고    scopus 로고
    • In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis
    • Saudemont A, Quesnel B. In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 2004;104:2124-33.
    • (2004) Blood , vol.104 , pp. 2124-2133
    • Saudemont, A.1    Quesnel, B.2
  • 127
    • 79960967930 scopus 로고    scopus 로고
    • PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation
    • Norde WJ, Maas F, Hobo W, et al. PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation. Cancer Res 2011;71:5111-22.
    • (2011) Cancer Res , vol.71 , pp. 5111-5122
    • Norde, W.J.1    Maas, F.2    Hobo, W.3
  • 128
    • 78751679810 scopus 로고    scopus 로고
    • PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells
    • Koestner W, Hapke M, Herbst J, et al. PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells. Blood 2011;117:1030-41.
    • (2011) Blood , vol.117 , pp. 1030-1041
    • Koestner, W.1    Hapke, M.2    Herbst, J.3
  • 129
    • 80051930238 scopus 로고    scopus 로고
    • Cutting edge: a monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models
    • Flies DB, Wang S, Xu H, Chen L. Cutting edge: a monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models. J Immunol 2011;187:1537-41.
    • (2011) J Immunol , vol.187 , pp. 1537-1541
    • Flies, D.B.1    Wang, S.2    Xu, H.3    Chen, L.4
  • 131
    • 78650265250 scopus 로고    scopus 로고
    • New monoclonal antibodies against B-cell antigens: possible new strategies for diagnosis of primary cutaneous B-cell lymphomas
    • Fanoni D, Tavecchio S, Recalcati S, Balice Y, Venegoni L, Fiorani R, Crosti C, Berti E. New monoclonal antibodies against B-cell antigens: possible new strategies for diagnosis of primary cutaneous B-cell lymphomas. Immunol Lett 2011;134:157-60.
    • (2011) Immunol Lett , vol.134 , pp. 157-160
    • Fanoni, D.1    Tavecchio, S.2    Recalcati, S.3    Balice, Y.4    Venegoni, L.5    Fiorani, R.6    Crosti, C.7    Berti, E.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.